Smaio S.A (ALSMA) | Stock Overview & Key Data
Smaio S.A Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €9.10 on May 21, 2026
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Financial Highlights
Annual Income Flow
2024
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Smaio S.A
ALSMA
|
47.02M Small-cap | 1.63% | 12.95% | 27.30% | 31.13% | 41.79% | 128.87% | 219.42% | 65.36% | 65.36% | 65.36% | 65.36% |
|
Equasens
EQS
|
589.23M Mid-cap | -2.47% | 0.54% | 10.13% | -9.42% | -16.39% | -20.51% | -51.36% | -56.42% | 60.55% | 266.39% | 266.39% |
|
Cegedim S.A
CGM
|
188.10M Mid-cap | -3.20% | -0.17% | 1.15% | 1.15% | 1.15% | 6.91% | 6.91% | 6.91% | 6.91% | 6.91% | 6.91% |
|
Abl Diagnostics
ABLD
|
44.38M Small-cap | -2.29% | 44.92% | -0.58% | 11.76% | -10.94% | -37.25% | -41.03% | 51.33% | 95.43% | 36.80% | 36.80% |
|
Intrasense S.A
ALINS
|
11.80M Small-cap | 0.00% | 4.55% | -4.17% | -11.54% | 0.00% | -25.00% | -45.45% | -68.42% | -73.91% | -95.75% | -95.75% |
|
Media Lab S.p.A
MLLAB
|
8.06M Small-cap | 0.00% | -0.59% | 1.20% | 9.03% | -5.59% | 53.64% | 152.24% | 95.38% | -1.46% | -1.46% | -1.46% |
Ownership & Short Interest
Calculate Your Smaio S.A Investment Returns
Long-Term Investment Performance Analysis
Smaio S.A stock price in Apr 2022 was €5.37, A €1,000.00 lump sum investment in Smaio S.A made 4 years ago would be worth approximately €1,623.84 today, representing a solid return of 62.38%. This translates to an annualized return (CAGR) of 12.35%.
4 Years 1 Month Investment Scenario (Apr 2022 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is ALSMA's 52-week high and low?
- In the last 52 weeks, Smaio S.A reached a high of €9.10 (on May 21, 2026) and a low of €3.46 (on N/A).
- What is the market cap and P/E ratio for ALSMA?
- Curious about Smaio S.A's size and valuation? Its market capitalization stands at 47.02M. When it comes to valuation, the P/E ratio (trailing twelve months) is 16.30, and the forward P/E (looking ahead) is 33.04.
- Does ALSMA pay dividends? If so, what's the yield?
- As for dividends, Smaio S.A isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Smaio S.A's main competitors or similar companies to consider before investing?
When looking at Smaio S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Equasens
EQS589.23M Healthcare Health Information Services -20.51% -51.36% Cegedim S.A
CGM188.10M Healthcare Health Information Services 6.91% 6.91% Abl Diagnostics
ABLD44.38M Healthcare Health Information Services -37.25% -41.03% Intrasense S.A
ALINS11.80M Healthcare Health Information Services -25.00% -45.45% Media Lab S.p.A
MLLAB8.06M Healthcare Health Information Services 53.64% 152.24% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Smaio S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Smaio S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -24.00%, the Debt to Equity ratio from the most recent quarter is 41.76, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for ALSMA?
- Looking at Smaio S.A's growth, its revenue over the trailing twelve months (TTM) was €8M. Compared to the same quarter last year (YoY), quarterly revenue grew by 126.00%, and quarterly earnings saw a YoY growth of N/A.
- How much of ALSMA stock is held by insiders and institutions?
- Wondering who owns Smaio S.A stock? Company insiders (like executives and directors) hold about 73.09% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.